Literature DB >> 26645482

Structural and biophysical investigation of the interaction of a mutant Grb2 SH2 domain (W121G) with its cognate phosphopeptide.

Danai Papaioannou1, Sebastian Geibel1,2, Micha B A Kunze1, Christopher W M Kay1,3, Gabriel Waksman1.   

Abstract

The adaptor protein Grb2 is a key element of mitogenetically important signaling pathways. With its SH2 domain it binds to upstream targets while its SH3 domains bind to downstream proteins thereby relaying signals from the cell membranes to the nucleus. The Grb2 SH2 domain binds to its targets by recognizing a phosphotyrosine (pY) in a pYxNx peptide motif, requiring an Asn at the +2 position C-terminal to the pY with the residue either side of this Asn being hydrophobic. Structural analysis of the Grb2 SH2 domain in complex with its cognate peptide has shown that the peptide adopts a unique β-turn conformation, unlike the extended conformation that phosphopeptides adopt when bound to other SH2 domains. TrpEF1 (W121) is believed to force the peptide into this unusual conformation conferring this unique specificity to the Grb2 SH2 domain. Using X-ray crystallography, electron paramagnetic resonance (EPR) spectroscopy, and isothermal titration calorimetry (ITC), we describe here a series of experiments that explore the role of TrpEF1 in determining the specificity of the Grb2 SH2 domain. Our results demonstrate that the ligand does not adopt a pre-organized structure before binding to the SH2 domain, rather it is the interaction between the two that imposes the hairpin loop to the peptide. Furthermore, we find that the peptide adopts a similar structure when bound to both the wild-type Grb2 SH2 domain and a TrpEF1Gly mutant. This suggests that TrpEF1 is not the determining factor for the conformation of the phosphopeptide.
© 2015 The Protein Society.

Entities:  

Keywords:  GRB2; SH2 domain; peptide binding; structure

Mesh:

Substances:

Year:  2015        PMID: 26645482      PMCID: PMC4815410          DOI: 10.1002/pro.2856

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  37 in total

1.  Dead-time free measurement of dipole-dipole interactions between electron spins.

Authors:  M Pannier; S Veit; A Godt; G Jeschke; H W Spiess
Journal:  J Magn Reson       Date:  2000-02       Impact factor: 2.229

2.  Dimer formation through domain swapping in the crystal structure of the Grb2-SH2-Ac-pYVNV complex.

Authors:  N Schiering; E Casale; P Caccia; P Giordano; C Battistini
Journal:  Biochemistry       Date:  2000-11-07       Impact factor: 3.162

3.  Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.

Authors:  Pierre Nioche; Wang-Qing Liu; Isabelle Broutin; Franck Charbonnier; Marie-Thérèse Latreille; Michel Vidal; Bernard Roques; Christiane Garbay; Arnaud Ducruix
Journal:  J Mol Biol       Date:  2002-02-01       Impact factor: 5.469

Review 4.  The language of SH2 domain interactions defines phosphotyrosine-mediated signal transduction.

Authors:  Bernard A Liu; Brett W Engelmann; Piers D Nash
Journal:  FEBS Lett       Date:  2012-05-05       Impact factor: 4.124

5.  Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms.

Authors:  G Waksman; S E Shoelson; N Pant; D Cowburn; J Kuriyan
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

6.  Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.

Authors:  S K Liu; C J McGlade
Journal:  Oncogene       Date:  1998-12-17       Impact factor: 9.867

7.  Thermodynamic and Structural Effects of Macrocyclization as a Constraining Method in Protein-Ligand Interactions.

Authors:  John E Delorbe; John H Clements; Benjamin B Whiddon; Stephen F Martin
Journal:  ACS Med Chem Lett       Date:  2010-11-11       Impact factor: 4.345

8.  Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.

Authors:  M J Eck; S E Shoelson; S C Harrison
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  BALBES: a molecular-replacement pipeline.

Authors:  Fei Long; Alexei A Vagin; Paul Young; Garib N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2007-12-05
View more
  6 in total

1.  Crystal Structures and Thermodynamic Analysis Reveal Distinct Mechanisms of CD28 Phosphopeptide Binding to the Src Homology 2 (SH2) Domains of Three Adaptor Proteins.

Authors:  Satomi Inaba; Nobutaka Numoto; Shuhei Ogawa; Hisayuki Morii; Teikichi Ikura; Ryo Abe; Nobutoshi Ito; Masayuki Oda
Journal:  J Biol Chem       Date:  2016-12-06       Impact factor: 5.157

Review 2.  (S)Pinning down protein interactions by NMR.

Authors:  Kaare Teilum; Micha Ben Achim Kunze; Simon Erlendsson; Birthe B Kragelund
Journal:  Protein Sci       Date:  2017-02-14       Impact factor: 6.725

Review 3.  Expanding the Disorder-Function Paradigm in the C-Terminal Tails of Erbbs.

Authors:  Louise Pinet; Nadine Assrir; Carine van Heijenoort
Journal:  Biomolecules       Date:  2021-11-14

4.  The dynamics of free and phosphopeptide-bound Grb2-SH2 reveals two dynamically independent subdomains and an encounter complex with fuzzy interactions.

Authors:  Karoline Sanches; Icaro P Caruso; Fabio C L Almeida; Fernando A Melo
Journal:  Sci Rep       Date:  2020-08-03       Impact factor: 4.379

Review 5.  New technologies to analyse protein function: an intrinsic disorder perspective.

Authors:  Vladimir N Uversky
Journal:  F1000Res       Date:  2020-02-10

Review 6.  Recent advances in synthetic and medicinal chemistry of phosphotyrosine and phosphonate-based phosphotyrosine analogues.

Authors:  Nikolai Makukhin; Alessio Ciulli
Journal:  RSC Med Chem       Date:  2020-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.